MacFarlane Katie

Chief Commercial Officer at AGILE THERAPEUTICS INC · on record since May 22, 2014
Director at RespireRx Pharmaceuticals Inc. · on record since Sep 5, 2014

Insider trading activity of MacFarlane Katie

Transactions on record: 11; since Sep 5, 2014

Open-market buys: 0

Open-market sells: 0

Companies traded: 2; last filing Oct 2, 2020

Figures computed from official regulatory filings — .

Companies where MacFarlane Katie has traded

RespireRx Pharmaceuticals Inc.9 tx · Oct 2, 2020
AGILE THERAPEUTICS INC2 tx · Feb 10, 2016

Track record of MacFarlane Katie

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of MacFarlane Katie

Co-insiders of MacFarlane Katie

Aisling Capital Partners III LLCAGILE THERAPEUTICS INC
Aisling Capital Partners III LPAGILE THERAPEUTICS INC
ALLNUTT ROBERTRespireRx Pharmaceuticals Inc.
ALTOMARI ALFREDAGILE THERAPEUTICS INC
Attwood James A JrRespireRx Pharmaceuticals Inc.
AURORA CAPITAL CORPRespireRx Pharmaceuticals Inc.
AURORA CAPITAL LLCRespireRx Pharmaceuticals Inc.
BARBARI SHARON SURREYAGILE THERAPEUTICS INC
BARRON BRUCE NRespireRx Pharmaceuticals Inc.
Battaglia SilvanaRespireRx Pharmaceuticals Inc.
Baumann WernerRespireRx Pharmaceuticals Inc.
Benedik John FRespireRx Pharmaceuticals Inc.
Boratto Eva CRespireRx Pharmaceuticals Inc.
BREUIL ROBERT SRespireRx Pharmaceuticals Inc.
Butch JasonAGILE THERAPEUTICS INC
Campbell Elizabeth SRespireRx Pharmaceuticals Inc.
Care Capital Offshore Investments III LPAGILE THERAPEUTICS INC
Carley David W.RespireRx Pharmaceuticals Inc.
Carlyle Holdings I GP Sub L.L.C.RespireRx Pharmaceuticals Inc.
Carlyle Realty III, L.P.RespireRx Pharmaceuticals Inc.
Carlyle Realty IV, L.P.RespireRx Pharmaceuticals Inc.
Carlyle Realty V GP, L.L.C.RespireRx Pharmaceuticals Inc.
Carlyle Realty V, L.P.RespireRx Pharmaceuticals Inc.
Carson SandraAGILE THERAPEUTICS INC
CASAMENTO CHARLES JRespireRx Pharmaceuticals Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	AwardD (derivative)	5,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Aug 4, 2020	AwardD (derivative)	7,500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Dec 12, 2017	OtherD (derivative)	38,114	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 5, 2017	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jan 20, 2017	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Apr 4, 2016	AwardD (derivative)	10,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
AGILE THERAPEUTICS INCListing unverified	Feb 10, 2016	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Aug 20, 2015	AwardD (derivative)	3,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 2, 2015	AwardD (derivative)	2,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
AGILE THERAPEUTICS INCListing unverified	Feb 23, 2015	AwardD (derivative)	21,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Sep 5, 2014	Award	2,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
RespireRx Pharmaceuticals Inc.Listing unverified	Oct 2, 2020	AwardD (derivative)	5,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Aug 4, 2020	AwardD (derivative)	7,500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Dec 12, 2017	OtherD (derivative)	38,114	—	n/a (No price was disclosed in the filing)	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 5, 2017	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jan 20, 2017	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Apr 4, 2016	AwardD (derivative)	10,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
AGILE THERAPEUTICS INCListing unverified	Feb 10, 2016	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Aug 20, 2015	AwardD (derivative)	3,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jul 2, 2015	AwardD (derivative)	2,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
AGILE THERAPEUTICS INCListing unverified	Feb 23, 2015	AwardD (derivative)	21,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Sep 5, 2014	Award	2,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC